CD4 and non-small cell lung carcinoma: Significant differences were found in MC10 (CD4+/CD185+) with the decrease in exCOPD and NSCLC (Figure 2A); the merged MC13 and MC14 were the CD38bright CD4+ T cells (CD38++ MCs) with the highest frequency in exCOPD (Figure 2B); conversely, the CD183+ MCs (MC5+MC6+MC8+MC10) were the lowest in exCOPD (Figure 2C).